Sign In
About ASHM | Careers | Your Cart Shoppint Cart
Skip Navigation LinksASHM Internet Home > ASHM Courses > Hepatitis C in Drug and Alcohol Settings Education Program
Open

Type

Public Training

When & Where

Novotel Canberra

Canberra ACT

November 5, 2017

8:30 AM to 5:30 PM

Fee

0.00

Hepatitis C in Drug and Alcohol Settings Education Program

Hepatitis C |
1 Day Course; 1/2 Day Course |
GPs |
People who inject drugs |
ACT |
|
This session has been developed in collaboration with drug & alcohol clinicians, hepatology specialists, GPs, nurses and representatives from drug user community organisations.

Only clinicians able to prescribe can attend

 

 

Please click here to download the Course Flyer

This Education Program is designed to give participants the confidence, knowledge and clinical decision-making skills to be able to prescribe new Direct Acting Antiviral (DAA) Therapy for the treatment of HCV infection, either independently or in collaboration with a specialist as appropriate.

The course will be delivered in three parts:

• Part 1 consists of a 2 hour eLearning component introducing the learner to the assessment, management and treatment of hepatitis C in drug and alcohol settings.

• Part 2 consists of an interactive face-to-face workshop building on the knowledge and skills gained in Part 1 through practical case discussions and simulation-based models.

• Part 3 consists of a tailored capacity strengthening toolkit including: a checklist for the assessment and treatment of HCV in drug and alcohol settings; local referral pathways; Fibroscan® access forms; assessment pro forma; and quick reference guides.

Learning Outcomes:

• Describe the risk factors for HCV infection enabling effective practice screening processes and recall systems

• Demonstrate competence interpreting clinical and other relevant information to provide effective care of people living with HCV infection

• Demonstrate competence in liver disease assessment

• Demonstrate understanding of DAA therapy for the treatment of HCV and competence in selecting and prescribing appropriate therapy

• Monitor patients on treatment and post-treatment appropriately

TARGET AUDIENCE:

Addiction Specialists, Physicians, General Practitioners, Nurse Practitioners and other clinical staff interested in treating hepatitis C

INCLUSIONS:

Morning Tea, Lunch and Afternoon Tea to be provided.

This workshop has been supported by Gilead Sciences Ltd.

For further Information Contact:

Natalie Huska (Project support Officer):

T 02 8204 0784

E Natalie.huska@ashm.org.au

Conditions of registration:

Registration Cancellations:

Registration cancellations and amendments must be notified in writing to ASHM. Cancellations received before 29 October will not incur a cancellation fee. Cancellations received in writing after 2 9 October 2017 will incur a $70 per day cancellation fee. This fee may be waived in exceptional circumstances at the discretion of ASHM.

Substitutions:

As an alternative to cancellation, your registration may be transferred to another person without incurring any penalty. ASHM must be advised of the transfer in writing. Please email the name, position, phone and email address of the new delegate to education@ashm.org.au.

Related Courses

 

 

Hepatitis B Nursing - Preventing Liver Cancer in Primary Care Workshophttp://www.ashm.org.au/Courses/Pages/EVT-01702-STTO.aspxHepatitis B Nursing - Preventing Liver Cancer in Primary Care Workshop22/03/2017 11:59:00 AMNSWThis course is targeted at primary health care nurses who are caring for patients with, or at risk of, chronic hepatitis B.Surry Hills
Strengthening BBV & STI Testing and Management in Aboriginal and Islander Health Settingshttp://www.ashm.org.au/Courses/Pages/EVT-01753-MH68.aspxStrengthening BBV & STI Testing and Management in Aboriginal and Islander Health Settings28/03/2017 11:59:00 AMQLDAn opportunity to improve testing and management of BBVs and STIs in rural and remote Aboriginal Community Controlled Health Services.Bowen
Hepatitis B Prescriber Update Evening: Interactive Case Discussion Sessionhttp://www.ashm.org.au/Courses/Pages/EVT-01773-14QY.aspxHepatitis B Prescriber Update Evening: Interactive Case Discussion Session28/03/2017 11:59:00 AMNSWAn educational evening for prescribers will be held in Sydney focusing on the decision to commence a patient on antiviral therapy, adherence, monitoring, and pregnancy.Sydney
Curing Hepatitis C: An update for primary care providers http://www.ashm.org.au/Courses/Pages/EVT-01751-GF7U.aspxCuring Hepatitis C: An update for primary care providers 29/03/2017 11:59:00 AMNSWThis hepatitis C update will focus on early diagnosis, management and treatment of hepatitis C in the context of new treatments which offer cure to most people. Nowra
Preparing Patients for Interferon-free Treatment for Hepatitis C in Drug and Alcohol Settingshttp://www.ashm.org.au/Courses/Pages/EVT-01747-UFHB.aspxPreparing Patients for Interferon-free Treatment for Hepatitis C in Drug and Alcohol Settings29/03/2017 11:59:00 AMNSWThis education session is designed to support staff working in Drug & Alcohol settings to manage their clients through the new treatment paradigm.Brighton-Le-Sands

Please enter a valid E-mail.
This must match your colleagues E-mail.
Please enter your name.
Please enter a valid email.
This must match your email.